NasdaqGM:WVEPharmaceuticals
Wave Life Sciences (WVE) Valuation In Focus As Obesity Data, Equity Raise And Conference Updates Draw Attention
Wave Life Sciences (WVE) has been in focus as investors look ahead to Phase 1 follow up data for obesity candidate WVE-007, alongside a recent equity raise intended to fund operations into late 2028.
See our latest analysis for Wave Life Sciences.
Recent trading has been choppy, with a 1 day share price return of 1.85% at a share price of $15.43, following a 30 day share price return decline of 16.68%. However, the 90 day share price return of 88.40% and 1 year total shareholder return of...